2022
DOI: 10.1111/cod.14202
|View full text |Cite
|
Sign up to set email alerts
|

Allergic contact dermatitis from resacetophenone (2′,4′‐dihydroxyacetophenone; CAS no. 89‐84‐9) in an antifungal nail preparation

Abstract: We report the first two cases of allergic contact dermatitis from resacetophenone in a nail antifungal preparation. Patch tests gave positive reactions to resacetophenone (0.1% and 1% pet.). No cross‐reactions with resorcinol or phenylethyl resorcinol were found. Patch testing with individual ingredients is paramount to diagnose new allergens.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 6 publications
0
4
0
Order By: Relevance
“…The pure chemical is an irritant 12 . Contact allergy to it in the same antifungal product has recently been reported 1 …”
Section: Discussionmentioning
confidence: 96%
See 2 more Smart Citations
“…The pure chemical is an irritant 12 . Contact allergy to it in the same antifungal product has recently been reported 1 …”
Section: Discussionmentioning
confidence: 96%
“…12 Contact allergy to it in the same antifungal product has recently been reported. 1 Acetophenone azine is an emerging contact allergen that often is associated with the use of sports equipment 13 and footwear 14 containing the foam elastomer ethyl vinyl acetate. The compound is probably not intentionally added to ethyl vinyl acetate but is likely the result of reactions between other additives that take place during the manufacturing process.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…ACD to 2,4‐dihydroxyacetophenone (resacetophenone; CAS 89‐84‐9), a related compound present in antifungal nail preparations, 9 has been recently described, but cross‐reactivity between both compounds has not yet been explored. Resacetophenone could not be patch tested in our patient.…”
Section: Discussionmentioning
confidence: 99%